Back to top

 

 

Founded in Evidence

 

Scientific study database

Swiss DolorClast® devices are the most researched devices in clinical trials published on shock wave therapy in the PEDro database. Find these and other studies in our comprehensive library below to learn the evidence behind Guided DolorClast Therapy and how it can boost your practice's success.

 

Improving extracorporeal shock wave therapy with 904 or 905 nm pulsed, high power laser pre-treatment

Prof. Dr. med. Christoph Schmitz
Extracorporeal Shock Wave Research Unit, Chair of Neuroanatomy, Institute of Anatomy, Faculty of Medicine, LMU Munich, Munich, Germany

Extracorporeal shock wave therapy (ESWT) is a well-investigated and commonly used treatment modality in remedying a variety of musculoskeletal disorders. Combining High Power 905nm laser treatment and ESWT may increase the beneficial use of ESWT in physical and rehabilitation medicine.

Home training, local corticosteroid injection, or radial shock wave therapy for greater trochanter pain syndrome.

Rompe JD, Segal NA, Cacchio A, et al.
Am J Sports Med 2009;37 1981-1990

RSWT® is a safe and effective method of treating greater trochanteric pain syndrome. DolorClast® Radial Shock Waves provided better results in a shorter time than home training.  

This randomized controlled clinical trial study aimed to determine whether local corticosteroid injection, home training, and repetitive low-energy shock wave therapy provide outcomes of equal value four months from baseline. 
 

Radial extracorporeal shock wave therapy is safe and effective in the treatment of chronic recalcitrant plantar fasciitis: results of a confirmatory randomized placebo-controlled multicenter study.

Gerdesmeyer L, Frey C, Vester J, et al.
Am J Sports Med 2008;36:2100- 2109

Chronic plantar fasciopathy can be treated efficiently with radial shock wave therapy, which can be administered to outpatients without having to reccur to anesthesia. This randomized controlled trial aims at demonstrating therapeutic superiority vs. placebo.